Ascendis Pharma A/S Ordinary Share

ASNDNASDAQUSD
246.73 USD
6.96 (2.90%)🟢LIVE (AS OF 12:07 PM EDT)
🟢Market: OPEN

Ascendis Pharma A/S Ordinary Share (ASND) is currently trading at $246.73. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9 and a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Sep 15, 2026.

Open?$239.70
High?$246.95
Low?$235.08
Prev. Close?$239.77
Volume?372.2K
Avg. Volume?N/A
VWAP?$241.14
Bid / Ask
Bid?$243.78 × 100
Ask?$257.23 × 200
Spread?$13.45
Midpoint?$250.51
Valuation & Ratios
Market Cap?15.8B
Shares Out?N/A
Float?46.6M
Float %?75.1%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Employees
1.2K
Market Cap
15.8B
Industry
N/A
Listed
2026-04-20
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
100
Momentum?
50
Short Sent.?
29
Piotroski F-Score?1/9Weak
Altman Z-Score?311.38Safe
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?9.03%Elevated
Short Interest?4.2M
Days to Cover?9.5
Free Float46.6M
Avg Daily Volume442.6K
Settlement Date2026-08-31